HER2 IHC Refresher Training
Global Ring Study HER2 IHC Testing in Breast Cancer
March 31st, 2023 (09:00 CEST), April 05th, 2023 (09:00 CEST), April 05th, 2023 (09:00 EDT), April 12th, 2023 (09:00 CEST), April 12th, 2023 (09:00 EDT), April 18th, 2023 (09:00 CEST)

Hosts:
Prof. Dr. med. Hans-Ulrich Schildhaus
Speaker:
Prof. Dr. med. Hans-Ulrich Schildhaus
Prof. Dr. med. Sunil Badve
Dr. med. Katja Schmitz
Dr. med. Fouad Alchami
Dear colleagues,
A precise HER2 assessment is the basis for the decision to treat breast cancer and for optimal patient care. Challenges in this process include accurate quantification of HER2 staining intensity, membrane or cytoplasmic staining, sample quality and the assay selection.
The focus of this particular HER2 IHC Refresher Training is to improve the skills to distinguish HER2 expression in the lower ranges across different HER2 assays.
Registration:
Contact us
If you have further questions or problems with the registration, you can also register by e-mail: Biomarker.Academy@dls.com
You can contact us at any time if you have further questions about the issue of privacy and data protection by emailing our Global Privacy Officer at Compliance@dls.com or our external data protection officer:
Dr. Barbara Tomasi
MyData-TRUST
DPO.DLS@mydata-trust.info
Phone: +49 32 212296564
We ensure, that the content of this educational course is designed product and serviceneutral. We assure that potential conflicts of interest between the organizer, the scientific lead and the speaker will be disclosed towards the participants (e.g. on the first slide of a presentation, an handout, link, download or notice). This event is sponsored by Daiichi Sankyo and AstraZeneca.